Literature DB >> 30325795

An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.

Daiwei Han1, Marjolein A Heuvelmans1,2, Rozemarijn Vliegenthart1,3, Mieneke Rook1,4, Monique D Dorrius1,3, Matthijs Oudkerk1.   

Abstract

While lung cancer screening has been implemented in the United States, it is still under consideration in Europe. So far, lung cancer screening trials in Europe were not able to replicate the results of the National Lung Screening Trial, but they do show a stage shift in the lung cancers that were detected. While eagerly awaiting the final result of the only lung cancer screening trial with sufficient statistical power, the NELSON trial, a number of European countries and medical societies have published recommendations for lung cancer screening using computed tomography. However, there is still a debate with regard to the design of future lung cancer screening programs in Europe. This review summarizes the latest evidence of European lung cancer screening trials and gives an overview of the essence of recommendations from the different European medical societies and countries.

Entities:  

Mesh:

Year:  2019        PMID: 30325795     DOI: 10.1097/RTI.0000000000000367

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  8 in total

Review 1.  Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.

Authors:  Matthijs Oudkerk; ShiYuan Liu; Marjolein A Heuvelmans; Joan E Walter; John K Field
Journal:  Nat Rev Clin Oncol       Date:  2020-10-12       Impact factor: 66.675

2.  Influence of Psychological Nursing Procedure on Negative Emotion, Stress State, Quality of Life and Nursing Satisfaction in Patients with Lung Cancer Radical Operation.

Authors:  Yizhi Yu; You Xia; Xiaoyan Fan; Yong Chen; Chengjuan Li; Jing Zhang
Journal:  Front Surg       Date:  2022-05-04

3.  Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program.

Authors:  Gregory P LeMense; Ernest A Waller; Cheryl Campbell; Tyler Bowen
Journal:  BMC Pulm Med       Date:  2020-04-29       Impact factor: 3.317

4.  Epidemiology and Survival Outcomes for Patients With NSCLC in Scandinavia in the Preimmunotherapy Era: A SCAN-LEAF Retrospective Analysis From the I-O Optimise Initiative.

Authors:  Simon Ekman; Pia Horvat; Mats Rosenlund; Anne Mette Kejs; Dony Patel; Ariadna Juarez-Garcia; Laure Lacoin; Melinda J Daumont; John R Penrod; Odd Terje Brustugun; Jens Benn Sørensen
Journal:  JTO Clin Res Rep       Date:  2021-03-24

Review 5.  The half-painted picture: Reviewing the mental health impacts of cancer screening.

Authors:  Lauren P Wadsworth; Inga Wessman; Andri Steinþór Björnsson; Gudbjorg Jonsdottir; Sigurður Yngvi Kristinsson
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

6.  Is the Yedikule-solitary pulmonary nodule malignancy risk score sufficient to predict malignancy? An internal validation study.

Authors:  Volkan Erdoğu; Necati Çitak; Aynur Yerlioğlu; Yunus Aksoy; Yasemin Emetli; Atilla Pekçolaklar; Özkan Saydam; Muzaffer Metin
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

7.  Direct and indirect healthcare costs of lung cancer CT screening in Denmark: a registry study.

Authors:  Manja Dahl Jensen; Volkert Siersma; Jakob Fraes Rasmussen; John Brodersen
Journal:  BMJ Open       Date:  2020-01-21       Impact factor: 2.692

8.  Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.

Authors:  Frank M Sullivan; Frances S Mair; William Anderson; Pauline Armory; Andrew Briggs; Cindy Chew; Alistair Dorward; John Haughney; Fiona Hogarth; Denise Kendrick; Roberta Littleford; Alex McConnachie; Colin McCowan; Nicola McMeekin; Manish Patel; Petra Rauchhaus; Lewis Ritchie; Chris Robertson; John Robertson; Jose Robles-Zurita; Joseph Sarvesvaran; Herbert Sewell; Michael Sproule; Thomas Taylor; Agnes Tello; Shaun Treweek; Kavita Vedhara; Stuart Schembri
Journal:  Eur Respir J       Date:  2021-01-14       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.